Document Details
Form
Filing Date
Sep 14, 2023
Document Date
Sep 14, 2023
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Neumora Therapeutics, Inc.
Issuer
NEUMORA THERAPEUTICS, INC.
Filer
AMGEN INC